Softwr

Research · head to head

Genedata vs Reduct

Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Rated
-
Full reviewWebsite
Reduct logo

Reduct

Research

Edit video by editing its transcript, built for researchers rather than video editors

From
$12/month
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.; Reduct automatic transcription struggles with technical vocabulary, product names and strong accents, so teams working in specialist domains spend real time correcting transcripts or pay extra for the human transcription add-on, which erodes the cost advantage.
  • They diverge on capability: Genedata covers Screener, Reduct covers Transcript-based editing.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Genedata and Reduct actually diverge.

Attributes where Genedata and Reduct differ
AttributeGenedataReduct
Starting priceOn request$12/month
Pricing modelquotePer user per month
PlatformsWeb, On-premise, Private cloudWeb, API

Identical on both: free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • Instrument integration
  • GxP-capable deployments

Only in Reduct

  • Transcript-based editing
  • Automatic transcription
  • Human transcription add-on
  • Highlight and tagging
  • Reel assembly
  • Redaction
  • Multicam sync
  • Collaborative commenting

What people use each for

The jobs each tool is most often brought in to do.

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot Reduct
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot Reduct
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot Reduct
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot Reduct

Reduct

  • A research team that runs twenty customer interviews a quarter and needs stakeholders across product and design to watch and comment without buying them seatsnot Genedata
  • A researcher assembling a five-minute highlight reel of user pain points for an executive review, working from transcript text rather than a video timelinenot Genedata
  • A public defender office redacting faces and identifying details from body-camera and interview footage before disclosurenot Genedata
  • A global insights team transcribing and translating interviews across several languages before coding them thematicallynot Genedata

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.

Reduct

  • Automatic transcription struggles with technical vocabulary, product names and strong accents, so teams working in specialist domains spend real time correcting transcripts or pay extra for the human transcription add-on, which erodes the cost advantage.
  • Transcription hours are a pooled annual allowance rather than monthly, so a team that front-loads a large research programme in one quarter can exhaust the year and face overage charges for the remaining nine months.
  • The Personal tier caps file size at 4GB, which is easily exceeded by an hour of multicam or high-bitrate recording, forcing an upgrade for reasons unrelated to the feature set.
  • Independent review coverage is very thin, so there is little public evidence to check vendor claims against, and buyers effectively have to rely on their own trial rather than peer signal.
  • The company has raised only about 4 million USD since 2018 and remains small, which makes enterprise vendor viability review and data-export planning genuinely necessary before you make it the home of years of research recordings.

Pricing, plan by plan

Genedata

On request
  • Genedata platform licence$undefined/year
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

Reduct

$12/month
  • Personal$12/month
    • 120 transcription hours per editor per year
    • Up to 10 commenters
    • 720p export
  • Professional$40/month
    • 300 transcription hours per editor per year
    • Up to 50 commenters
    • Timeline view
  • Enterprise$75/month
    • 4K export
    • SAML and Google SSO
    • SOC 2 Type II

Which should you pick?

Choose Genedata if

  • You need screener.
  • You work on Web, On-premise, Private cloud.
  • You also want biologics.
Genedata review

Choose Reduct if

  • You need transcript-based editing.
  • You work on Web, API.
  • You also want automatic transcription.
Reduct review

Questions people ask

Is Genedata or Reduct better?
Neither clearly leads. Genedata starts at On request and Reduct at $12/month, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Genedata or Reduct?
Genedata starts at On request and Reduct at $12/month.
Does Genedata or Reduct run on more platforms?
Genedata runs on Web, On-premise, Private cloud. Reduct runs on Web, API.
What is Genedata best used for?
Genedata is most often used for a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale, a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets, a process development group standardising bioprocess run data across sites for modelling and scale-up, a cro delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelines. Of those, a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale and a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets are not what Reduct is typically brought in for.
What can Genedata do that Reduct cannot?
Genedata covers Screener, Biologics, Bioprocess, Expressionist. Reduct covers Transcript-based editing, Automatic transcription, Human transcription add-on, Highlight and tagging.

Answered from the vendors’ own pages

Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

Reduct: How is Reduct priced?

Per editor per month: 12 USD on Personal, 40 on Professional and from 75 on Enterprise, with transcription supplied as a pooled annual hour allowance per editor.

Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

Reduct: Do stakeholders who only watch and comment need a paid seat?

No. Commenters are separate from editor seats and included up to 10 on Personal and 50 on Professional, which is the main reason research teams choose it.

Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

Reduct: Can I use it as a proper video editor?

Only up to a point. It handles transcript-driven cutting, reels and multicam sync, then exports to Premiere Pro or Final Cut Pro when you need real finishing.

Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

Reduct: Is there a free tier?

No. There is a 14-day trial on Professional with five hours of transcription, but no permanent free plan.

Share

Related pages

More on Genedata

More on Reduct

Keep looking

Other head to heads